Literature DB >> 33215931

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Steve R Ommen1, Seema Mital1, Michael A Burke1, Sharlene M Day1, Anita Deswal2,3, Perry Elliott1, Lauren L Evanovich1, Judy Hung4, José A Joglar1, Paul Kantor1, Carey Kimmelstiel1, Michelle Kittleson1, Mark S Link5, Martin S Maron6, Matthew W Martinez1, Christina Y Miyake1, Hartzell V Schaff7, Christopher Semsarian1, Paul Sorajja8.   

Abstract

Entities:  

Keywords:  AHA Scientific Statements; atrial fibrillation; cardiovascular magnetic resonance; diastolic dysfunction; echocardiography; exercise stress testing; family screening; genetics; guidelines; hypertrophic cardiomyopathy; implantable cardioverter defibrillator; left ventricular outflow tract obstruction; occupation; physical activity; pregnancy; rhythm monitoring; risk stratification; sarcomeric genes; septal alcohol ablation; septal reduction therapy; shared decision-making; sudden cardiac death; surgical myectomy; systolic dysfunction; ventricular arrhythmias

Mesh：

Year:  2020        PMID： 33215931     DOI： 10.1161/CIR.0000000000000937

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  65 in total

Review 1.  Cardiac Imaging for the Assessment of Left Atrial Mechanics Across Heart Failure Stages.

Authors:  Francesco Bandera; Anita Mollo; Matteo Frigelli; Giulia Guglielmi; Nicoletta Ventrella; Maria Concetta Pastore; Matteo Cameli; Marco Guazzi
Journal:  Front Cardiovasc Med       Date:  2022-01-13

2.  Posterior mitral leaflet plication with extended septal myectomy for hypertrophic obstructive cardiomyopathy.

Authors:  Praveen Kerala Varma; Kirun Gopal; Hisham Ahamed; Sudheer Babu Vanga
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-06-08

3.  Coronary microvascular disease in hypertrophic and infiltrative cardiomyopathies.

Authors:  Andreas A Giannopoulos; Ronny R Buechel; Philipp A Kaufmann
Journal:  J Nucl Cardiol       Date:  2022-08-01       Impact factor: 3.872

4.  Elevated baseline serum creatine kinase in Thai early systemic sclerosis patients is associated with high incidence of cardiopulmonary complications and poor survival: an inception cohort study.

Authors:  Suparaporn Wangkaew; Jirapath Intum; Narawudt Prasertwittayakij; Juntima Euathrongchit
Journal:  Clin Rheumatol       Date:  2022-07-07       Impact factor: 3.650

Review 5.  Incorporating Cascade Effects of Genetic Testing in Economic Evaluation: A Scoping Review of Methodological Challenges.

Authors:  Alexandra Cernat; Robin Z Hayeems; Lisa A Prosser; Wendy J Ungar
Journal:  Children (Basel)       Date:  2021-04-27

Review 6.  Hypertrophic Cardiomyopathy and Primary Restrictive Cardiomyopathy: Similarities, Differences and Phenocopies.

Authors:  Riccardo Vio; Annalisa Angelini; Cristina Basso; Alberto Cipriani; Alessandro Zorzi; Paola Melacini; Gaetano Thiene; Alessandra Rampazzo; Domenico Corrado; Chiara Calore
Journal:  J Clin Med       Date:  2021-05-01       Impact factor: 4.241

7.  Targeting Alcohol Septal Ablation in Patients with Obstructive Hypertrophic Cardiomyopathy Candidates for Surgical Myectomy: Added Value of Three-Dimensional Intracoronary Myocardial Contrast Echocardiography.

Authors:  Giovanni La Canna; Iside Scarfò; Irina Arendar; Antonio Colombo; Lucia Torracca; Davide Margonato; Matteo Montorfano; Ottavio Alfieri
Journal:  J Clin Med       Date:  2021-05-17       Impact factor: 4.241

8.  Risk Factors of Pulmonary Arterial Hypertension and Its Relationship With Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy.

Authors:  Changrong Nie; Changsheng Zhu; Minghu Xiao; Zhengyang Lu; Qiulan Yang; Yanhai Meng; Rong Wu; Shuiyun Wang
Journal:  Front Cardiovasc Med       Date:  2021-07-07

Review 9.  Pushing the Limits of Medical Management in HCM: A Review of Current Pharmacological Therapy Options.

Authors:  Cristian Stătescu; Ștefana Enachi; Carina Ureche; Laura Țăpoi; Larisa Anghel; Delia Șalaru; Carmen Pleșoianu; Mădălina Bostan; Dragoș Marcu; Mircea Ovanez Balasanian; Radu Andy Sascău
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

10.  Comprehensive Proteomics Profiling Reveals Circulating Biomarkers of Hypertrophic Cardiomyopathy.

Authors:  Yuichi J Shimada; Yoshihiko Raita; Lusha W Liang; Mathew S Maurer; Kohei Hasegawa; Michael A Fifer; Muredach P Reilly
Journal:  Circ Heart Fail       Date:  2021-07-01       Impact factor: 10.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.